Imiquimod 5% Cream in the Treatment of Human Papillomavirus-16-Positive Erythroplasia of Queyrat
- 1 July 2002
- journal article
- case report
- Published by S. Karger AG in Dermatology
- Vol. 205 (1) , 67-69
- https://doi.org/10.1159/000063140
Abstract
Erythroplasia of Queyrat is a human-papillomavirus-associated carcinoma in situ of the penis. Imiquimod, a new topically applied immunomodulatory agent, has been successfully used in the treatment of anogenital warts. We report the complete clearance of HPV-16-positive erythroplasia of Queyrat with 5% imiquimod cream.Keywords
This publication has 2 references indexed in Scilit:
- Imiquimod 5% cream in the treatment of Bowen's diseaseJournal of the American Academy of Dermatology, 2001
- Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary taleBritish Journal of Dermatology, 2000